Trial · NCT03180957
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Early Disease: Nodule Hardness at 12 Months | Anti-TNF | 58.1 | Standard Deviation 11.8 | Durometer Arbitrary Units (AU) | |
| Early Disease: Nodule Hardness at 12 Months | Placebo | 61.2 | Standard Deviation 9.8 | Durometer Arbitrary Units (AU) | |
| Early Disease: Nodule Size | Anti-TNF | 21.8 | Standard Deviation 18.7 | mm^2 | |
| Early Disease: Nodule Size | Placebo | 35.9 | Standard Deviation 28.9 | mm^2 | |
| Early Disease: Grip Strength | Anti-TNF | 34.5 | Standard Deviation 10.7 | kg | |
| Early Disease: Grip Strength | Placebo | 38.3 | Standard Deviation 11.9 | kg | |
| Early Disease: Extension Deficit of Affected Joint | Anti-TNF | Overall passive extension deficit of joint affected by treatment nodule | 3.3 | Standard Deviation 10.2 | degrees |
| Early Disease: Extension Deficit of Affected Joint | Placebo | Overall passive extension deficit of joint affected by treatment nodule | 5.0 | Standard Deviation 12.8 | degrees |
| Early Disease: Extension Deficit of Affected Joint | Anti-TNF | MCP:passive extension deficit of joint affected by treated nodule | 0.0 | Standard Deviation 0.0 | degrees |
| Early Disease: Extension Deficit of Affected Joint | Placebo | MCP:passive extension deficit of joint affected by treated nodule | 1.4 | Standard Deviation 5.7 | degrees |
| Early Disease: Extension Deficit of Affected Joint | Anti-TNF | PIP: passive extension deficit of joint affected by treated nodule | 14.7 | Standard Deviation 17.7 | degrees |
| Early Disease: Extension Deficit of Affected Joint | Placebo | PIP: passive extension deficit of joint affected by treated nodule | 30.0 | Standard Deviation 20.4 | degrees |
| Early Disease: Patient Reported Outcomes | Anti-TNF | 83.5 | Standard Deviation 16.1 | score on a scale | |
| Early Disease: Patient Reported Outcomes | Placebo | 78.8 | Standard Deviation 16.0 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03180957/results